Mustafa Nazzal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mustafa Nazzal has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
Chintalapati Varma
Saint Louis University School of Medicine, St. Louis, Missouri
5 shared publicationsRaymond I Okeke
5 shared publications- Yasar Caliskan
Division of Nephrology, Saint Louis University, St. Louis, USA
5 shared publications - Krista L. Lentine
SSM Health Saint Louis University Hospital, United States
4 shared publications Vidyaratna Fleetwood
4 shared publications- Ajay Jain
Department of Pediatrics, School of Medicine, Saint Louis University, 1402 S. Grand Blvd, St. Louis, MO 63104, USA
3 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Springer Nature in Cureus
- Vol. 18 (6)
Intraoperative Use of Extracorporeal Membrane Oxygenation (ECMO) During Liver Transplantation: A Case Report
Extracorporeal membrane oxygenation (ECMO) is increasingly used for cardiorespiratory support in hemodynamically unstable patients, yet standardized guidelines for its intraoperative use during liver transplantation are lacking. We present a retrospective review of two orthotopic liver transplant (OLT) recipients who required intraoperative veno-venous (VV) ECMO support. The first patient, a 52-year-old female with alcohol-related cirrhosis, developed acute pulmonary edema, rising oxygen requirements, and oliguric kidney injury, necessitating emergent VV ECMO during OLT. The second patient, a 66-year-old male with nonalcoholic steatohepatitis-related cirrhosis and severe hepatopulmonary syndrome, underwent planned intraoperative VV ECMO to optimize oxygenation. Both patients tolerated ECMO well and recovered with stable postoperative liver function and respiratory status at follow-up. These cases illustrate that intraoperative ECMO - whether emergent or planned - can be a valuable adjunct to manage severe cardiopulmonary instability during liver transplantation. Our findings support broader discussion and development of protocols guiding their use in this setting.
- 26 June 2026
- Published by Springer Nature in Cureus
- Vol. 18 (6)
Open AccessIntraoperative Use of Extracorporeal Membrane Oxygenation (ECMO) During Liver Transplantation: A Case Report
Extracorporeal membrane oxygenation (ECMO) is increasingly used for cardiorespiratory support in hemodynamically unstable patients, yet standardized guidelines for its intraoperative use during liver transplantation are lacking. We present a retrospective review of two orthotopic liver transplant (OLT) recipients who required intraoperative veno-venous (VV) ECMO support. The first patient, a 52-year-old female with alcohol-related cirrhosis, developed acute pulmonary edema, rising oxygen requirements, and oliguric kidney injury, necessitating emergent VV ECMO during OLT. The second patient, a 66-year-old male with nonalcoholic steatohepatitis-related cirrhosis and severe hepatopulmonary syndrome, underwent planned intraoperative VV ECMO to optimize oxygenation. Both patients tolerated ECMO well and recovered with stable postoperative liver function and respiratory status at follow-up. These cases illustrate that intraoperative ECMO - whether emergent or planned - can be a valuable adjunct to manage severe cardiopulmonary instability during liver transplantation. Our findings support broader discussion and development of protocols guiding their use in this setting.
- Open Access
- 17 April 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (5) , e1933
Clinical Utility of Standardized Genetic Testing in Kidney Transplant Candidate Evaluation
Background.: Genetic testing is increasingly used in the evaluation of kidney transplant (KT) candidates, yet its direct association with transplant-related outcomes remains unclear. This study assessed whether genetic test results are associated with key steps in the KT process. Methods.: In this observational cohort study, 270 KT candidates underwent standardized genetic testing between January 2021 and November 2024. The outcomes, including waitlisting and transplantation, were compared between candidates with and without positive results. Primary outcomes assessed clinical utility during transplant evaluation, including diagnostic reclassification of end-stage kidney disease (ESKD), effects on living donor evaluation, and genetic counseling. Secondary outcomes included waitlisting, transplantation, and post-transplant allograft function (estimated glomerular filtration rate). Results.: Among 270 KT candidates, indications for testing included family history (45.9%), hypertension-attributed ESKD without biopsy (30%), and ESKD of unknown etiology (24.4%). Positive genetic results were identified in 104 candidates (38.5%), who were younger and more frequently Black. Family history independently predicted a positive result (adjusted odds ratio = 1.91 and 95% confidence interval, 1.13-3.27; P = 0.02). Genetic kidney disease was identified in 36.4% of candidates with ESKD of unknown etiology and 43.2% of those with hypertension-attributed ESKD, most commonly APOL1 -mediated disease. APOL1 high-risk genotypes were present in 50% of focal segmental glomerulosclerosis cases. Overall, 75.9% received pretest counseling and positive results (n = 104) prompted post-test counseling (n = 85) and guided living donor risk assessment and evaluation for extrarenal manifestations. During follow-up, waitlisting, transplantation rates, and post-transplant estimated glomerular filtration rate did not differ between candidates with and without positive results ( P = 0.72, P = 0.35, and P = 0.06, respectively). Conclusions.: Genetic testing demonstrated a high diagnostic rate among KT candidates, particularly in identifying APOL1 -associated risk. Testing clarified disease etiology, informed recipient and family counseling, and supported safe living donor selection without affecting waitlisting. Integrating genetic testing into transplant evaluation may enhance precision medicine and transplant care.
- 17 April 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (5) , e1933
Open AccessClinical Utility of Standardized Genetic Testing in Kidney Transplant Candidate Evaluation
Background.: Genetic testing is increasingly used in the evaluation of kidney transplant (KT) candidates, yet its direct association with transplant-related outcomes remains unclear. This study assessed whether genetic test results are associated with key steps in the KT process. Methods.: In this observational cohort study, 270 KT candidates underwent standardized genetic testing between January 2021 and November 2024. The outcomes, including waitlisting and transplantation, were compared between candidates with and without positive results. Primary outcomes assessed clinical utility during transplant evaluation, including diagnostic reclassification of end-stage kidney disease (ESKD), effects on living donor evaluation, and genetic counseling. Secondary outcomes included waitlisting, transplantation, and post-transplant allograft function (estimated glomerular filtration rate). Results.: Among 270 KT candidates, indications for testing included family history (45.9%), hypertension-attributed ESKD without biopsy (30%), and ESKD of unknown etiology (24.4%). Positive genetic results were identified in 104 candidates (38.5%), who were younger and more frequently Black. Family history independently predicted a positive result (adjusted odds ratio = 1.91 and 95% confidence interval, 1.13-3.27; P = 0.02). Genetic kidney disease was identified in 36.4% of candidates with ESKD of unknown etiology and 43.2% of those with hypertension-attributed ESKD, most commonly APOL1 -mediated disease. APOL1 high-risk genotypes were present in 50% of focal segmental glomerulosclerosis cases. Overall, 75.9% received pretest counseling and positive results (n = 104) prompted post-test counseling (n = 85) and guided living donor risk assessment and evaluation for extrarenal manifestations. During follow-up, waitlisting, transplantation rates, and post-transplant estimated glomerular filtration rate did not differ between candidates with and without positive results ( P = 0.72, P = 0.35, and P = 0.06, respectively). Conclusions.: Genetic testing demonstrated a high diagnostic rate among KT candidates, particularly in identifying APOL1 -associated risk. Testing clarified disease etiology, informed recipient and family counseling, and supported safe living donor selection without affecting waitlisting. Integrating genetic testing into transplant evaluation may enhance precision medicine and transplant care.
- Open Access
Gender-Specific Gene Regulation of Ferroptosis in Non-Utilized Liver Donors
Background/Objectives: Females are generally more resistant to ischemia-related ferroptosis than males, due to differences in iron metabolism, antioxidant pathways, and sex hormone-mediated regulation of ferroptosis suppressors. This has not been systematically studied in a human donor liver model. To investigate the effect of sex on ferroptosis and oxidative stress pathways in non-utilized donor livers (NDLs), we assessed patterns of gene expression in NDLs under ex vivo normothermic machine perfusion (NMP). Methods: We utilized the PROTECT dual-circuit ex vivo NMP system to assess three male and two female NDLs undergoing 6 h NMP. Perfusate and tissue samples were collected at baseline and 6 h of NMP. Malondialdehyde (MDA) levels were quantified as biochemical markers of iron overload and lipid peroxidation, respectively. Ferroptosis-related gene expression was assessed using molecular assays. Comparisons between male and female NDLs were used to determine the influence of sex on ferroptosis and oxidative injury during NMP. Results: NMP was successfully performed on NDLs (n = 5) from three male (56.3 ± 5.7 years) and two female donors (46.5 ± 0.7 years, p = 0.15). The fold-change in the oxidative stress marker MDA was comparable between female (1.2 ± 0.6) and male (1.0 ± 0.4) NDLs after 6 h NMP (p = 0.76). All livers showed upregulation of ferroptosis-related genes (Hypoxia-inducible factor 1 alpha, Iron Responsive Binding Elements 2, Ribosomal Protein L8, Ferritin Heavy Chain 1, Acyl-CoA synthetase family member 2, ATP synthase membrane subunit c locus 3, Heme-oxygenase 1, NAD(P)H Quinone Dehydrogenase 1, Tetratricopeptide Repeat Domain 35, Nuclear Factor Erythroid 2 Related Factor 2). ACSF2 expression was significantly higher in female NDLs compared with males undergoing 6 h NMP (3.6 ± 3.0 vs. 1.0 ± 0.7-fold change, p = 0.04). There were no sex-based significant differences observed in the expression of other ferroptosis-related genes (HIF-1α, IREB2, RPL8, FTH-1, ATP5G3, HO-1, NQO1, TTC35, and NRF2) between male and female NDLs. No gene reached statistical significance after false-discovery-rate (FDR) correction. Conclusions: Normothermic machine perfusion of NDLs was feasible, and no sex-related differences were observed in MDA levels or most ferroptosis-related gene expression after 6 h. Although ACSF2 showed higher expression in female livers, this was not significant after multiple testing correction, highlighting the need for larger studies to explore sex-dependent ferroptosis signaling during liver preservation.
Open AccessGender-Specific Gene Regulation of Ferroptosis in Non-Utilized Liver Donors
Background/Objectives: Females are generally more resistant to ischemia-related ferroptosis than males, due to differences in iron metabolism, antioxidant pathways, and sex hormone-mediated regulation of ferroptosis suppressors. This has not been systematically studied in a human donor liver model. To investigate the effect of sex on ferroptosis and oxidative stress pathways in non-utilized donor livers (NDLs), we assessed patterns of gene expression in NDLs under ex vivo normothermic machine perfusion (NMP). Methods: We utilized the PROTECT dual-circuit ex vivo NMP system to assess three male and two female NDLs undergoing 6 h NMP. Perfusate and tissue samples were collected at baseline and 6 h of NMP. Malondialdehyde (MDA) levels were quantified as biochemical markers of iron overload and lipid peroxidation, respectively. Ferroptosis-related gene expression was assessed using molecular assays. Comparisons between male and female NDLs were used to determine the influence of sex on ferroptosis and oxidative injury during NMP. Results: NMP was successfully performed on NDLs (n = 5) from three male (56.3 ± 5.7 years) and two female donors (46.5 ± 0.7 years, p = 0.15). The fold-change in the oxidative stress marker MDA was comparable between female (1.2 ± 0.6) and male (1.0 ± 0.4) NDLs after 6 h NMP (p = 0.76). All livers showed upregulation of ferroptosis-related genes (Hypoxia-inducible factor 1 alpha, Iron Responsive Binding Elements 2, Ribosomal Protein L8, Ferritin Heavy Chain 1, Acyl-CoA synthetase family member 2, ATP synthase membrane subunit c locus 3, Heme-oxygenase 1, NAD(P)H Quinone Dehydrogenase 1, Tetratricopeptide Repeat Domain 35, Nuclear Factor Erythroid 2 Related Factor 2). ACSF2 expression was significantly higher in female NDLs compared with males undergoing 6 h NMP (3.6 ± 3.0 vs. 1.0 ± 0.7-fold change, p = 0.04). There were no sex-based significant differences observed in the expression of other ferroptosis-related genes (HIF-1α, IREB2, RPL8, FTH-1, ATP5G3, HO-1, NQO1, TTC35, and NRF2) between male and female NDLs. No gene reached statistical significance after false-discovery-rate (FDR) correction. Conclusions: Normothermic machine perfusion of NDLs was feasible, and no sex-related differences were observed in MDA levels or most ferroptosis-related gene expression after 6 h. Although ACSF2 showed higher expression in female livers, this was not significant after multiple testing correction, highlighting the need for larger studies to explore sex-dependent ferroptosis signaling during liver preservation.
- Open Access
- 1 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
The Use of MRI With Double-Dose Eovist for the Detection of Bile Leaks
Background and objectives Bile leaks are serious complications that can occur after liver transplant, hepatobiliary surgery, and abdominal trauma and can be challenging to diagnose. Noninvasive diagnostic studies for bile leaks are limited. In this study, we aimed to evaluate the efficacy of MRI with a double-dose of Eovist (gadoxetate disodium) in comparison with other imaging modalities for detecting biliary leaks. Methods This study involved a retrospective review of patients who underwent MRI with double-dose Eovist (dEovist) to evaluate suspected bile leakage from 2016 to 2022. Indications for evaluation included suspected bile leak after recent hepatobiliary surgery or penetrating right upper quadrant trauma. Once the dEovist study was performed and a bile leak was suspected, confirmation with endoscopic retrograde cholangiopancreatography (ERCP) was obtained. These results were statistically analyzed to determine the sensitivity and specificity of MRI with dEovist in detecting biliary leakage, and ERCP was used as the confirmatory test. Results A total of 19 patients were included. dEovist detected biliary leakage in five of 19 patients. All patients with concern for bile leak after MRI underwent ERCP for confirmation of the findings; four of these patients were confirmed as true positives, and one was determined to be a false positive. The remaining 14 patients with negative MRI findings with dEovist were followed clinically, and all had clinical courses that were not suggestive of bile leak. Six of these patients underwent ERCP, which also confirmed the absence of biliary leakage. The sensitivity of MRI with dEovist for detecting bile leaks in this study was 100% (95% confidence interval (CI): 39%, 100%), and the specificity was 93% (95% CI: 66%, 100%). Conclusions Prompt identification and early intervention are crucial for preventing the complications associated with bile leaks. The use of MRI with dEovist has shown promising results as a noninvasive imaging modality with high sensitivity and specificity in the detection of bile leaks.
- 1 February 2026
- Published by Springer Nature in Cureus
- Vol. 18 (2)
Open AccessThe Use of MRI With Double-Dose Eovist for the Detection of Bile Leaks
Background and objectives Bile leaks are serious complications that can occur after liver transplant, hepatobiliary surgery, and abdominal trauma and can be challenging to diagnose. Noninvasive diagnostic studies for bile leaks are limited. In this study, we aimed to evaluate the efficacy of MRI with a double-dose of Eovist (gadoxetate disodium) in comparison with other imaging modalities for detecting biliary leaks. Methods This study involved a retrospective review of patients who underwent MRI with double-dose Eovist (dEovist) to evaluate suspected bile leakage from 2016 to 2022. Indications for evaluation included suspected bile leak after recent hepatobiliary surgery or penetrating right upper quadrant trauma. Once the dEovist study was performed and a bile leak was suspected, confirmation with endoscopic retrograde cholangiopancreatography (ERCP) was obtained. These results were statistically analyzed to determine the sensitivity and specificity of MRI with dEovist in detecting biliary leakage, and ERCP was used as the confirmatory test. Results A total of 19 patients were included. dEovist detected biliary leakage in five of 19 patients. All patients with concern for bile leak after MRI underwent ERCP for confirmation of the findings; four of these patients were confirmed as true positives, and one was determined to be a false positive. The remaining 14 patients with negative MRI findings with dEovist were followed clinically, and all had clinical courses that were not suggestive of bile leak. Six of these patients underwent ERCP, which also confirmed the absence of biliary leakage. The sensitivity of MRI with dEovist for detecting bile leaks in this study was 100% (95% confidence interval (CI): 39%, 100%), and the specificity was 93% (95% CI: 66%, 100%). Conclusions Prompt identification and early intervention are crucial for preventing the complications associated with bile leaks. The use of MRI with dEovist has shown promising results as a noninvasive imaging modality with high sensitivity and specificity in the detection of bile leaks.
- Open Access
- 9 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10) , e94206
Changing Dynamics in Liver Allocation: Donor and Recipient Traits Pre- and Post Acuity Circle Implementation
Background: The Acuity Circle (AC) allocation model for liver transplantation was implemented in 2020 to address geographic disparities in organ access. The policy improves equity and waitlist outcomes by prioritizing disease severity and reducing regional boundaries. This study reviews transplant metrics and donor and recipient characteristics in the pre- and post-AC implementation era. Methods: Data from the National Standard Transplant Analysis and Research (STAR) file were analyzed for liver transplants performed between February 4, 2017, and February 3, 2023. Donor and recipient variables were assessed using chi-squared and t-tests. Geographic trends and changes in transplant volumes were analyzed. Results: Following the AC implementation, transplant volume rose by 10%, with a 558% national allocation increase and a 34% local allocation decrease (p<0.001), with an increase in average distance from the donor hospital to the transplant center. Cold ischemic time increased from 5.74 to six hours (p<0.001), while the average waitlist time decreased from 232 to 182 days (p<0.001). High-severity patients received more transplants, with MELD scores rising from 23.1 to 24.7 (p<0.001). Conclusions: The AC policy was associated with altered transplant allocation patterns, improved matching based on medical urgency, and reduced waitlist times. However, increased cold ischemic times and travel distances highlighted logistic challenges. While early trends show progress toward equity, further research is needed to address long-term effects and persistent geographic disparities.
- 9 October 2025
- Published by Springer Nature in Cureus
- Vol. 17 (10) , e94206
Open AccessChanging Dynamics in Liver Allocation: Donor and Recipient Traits Pre- and Post Acuity Circle Implementation
Background: The Acuity Circle (AC) allocation model for liver transplantation was implemented in 2020 to address geographic disparities in organ access. The policy improves equity and waitlist outcomes by prioritizing disease severity and reducing regional boundaries. This study reviews transplant metrics and donor and recipient characteristics in the pre- and post-AC implementation era. Methods: Data from the National Standard Transplant Analysis and Research (STAR) file were analyzed for liver transplants performed between February 4, 2017, and February 3, 2023. Donor and recipient variables were assessed using chi-squared and t-tests. Geographic trends and changes in transplant volumes were analyzed. Results: Following the AC implementation, transplant volume rose by 10%, with a 558% national allocation increase and a 34% local allocation decrease (p<0.001), with an increase in average distance from the donor hospital to the transplant center. Cold ischemic time increased from 5.74 to six hours (p<0.001), while the average waitlist time decreased from 232 to 182 days (p<0.001). High-severity patients received more transplants, with MELD scores rising from 23.1 to 24.7 (p<0.001). Conclusions: The AC policy was associated with altered transplant allocation patterns, improved matching based on medical urgency, and reduced waitlist times. However, increased cold ischemic times and travel distances highlighted logistic challenges. While early trends show progress toward equity, further research is needed to address long-term effects and persistent geographic disparities.
- Open Access
APOL1-Risk Genotype Induces Inflammatory and Hypoxic Gene Expression in Donor Kidneys
Background/Objectives: APOL1 renal-risk variants (RRVs) are of increasing relevance to kidney disease and transplant outcomes. It is currently understood that the presence of RRVs in donors negatively impacts kidney allograft survival in an autosomal recessive pattern of inheritance. Less well known is the interplay between ischemia and alternative allograft preservation methods, such as normothermic machine perfusion (NMP), on APOL1 gene expression. To investigate this, we examined the effects of APOL1 RRVs on APOL1 gene expression in ischemic donor kidneys and compared the differences in cytokine and APOL1 expression patterns between the alternative preservation methods, static cold storage (CS) and NMP. Methods: Non-utilized deceased donor kidney pairs from donors of African ancestry were procured from Mid-America Transplant after being deemed unsuitable for kidney transplant. Samples were collected from each donor kidney pair and DNA was extracted for APOL1 genotyping. APOL1 RRVs G1 (rs73885319) (rs60910145) and G2 (rs71785313) were identified by Sanger sequencing. From each pair, one kidney underwent 6 h NMP (n = 3) and the contralateral kidney 6 h of CS (n = 3) following the initial CS. Renal perfusion and biochemical, and histologic parameters were recorded. NMP was directly compared with CS using paired donor kidneys using NMP with allogeneic red blood cells, followed by assessment of perfusion, biochemical, and histologic parameters, in addition to gene expression. Results: Donor genotyping identified kidney pairs as heterozygous for the G1 RRV (G1/G0), homozygous for the G0 allele (G0/G0), and homozygous for the G2 RRV (G2/G2), respectively. All kidneys were successfully reperfused, with mRNA transcript levels of APOL1-related genes subsequently measured. Significant differences in APOL1 gene expression were observed among all three groups of kidneys. In paired kidneys from baseline to hour 6 of NMP, mRNA expression varied significantly between G1/G0 and G2/G2 homozygous pairs (p = 0.002) as well as between the G0/G0 and G2/G2 pairs (p = 0.002). APOL1 expression shifted by a significantly higher-fold change of 2.4 under NMP conditions in the G2/G2 genotype (p < 0.001). The inflammatory cytokine marker IFN-γ was also significantly upregulated in the G2/G2 genotype kidney, in both CS and NMP groups (p = 0.001). Other related genes such as KIM-1 were upregulated by a change of 3.9-fold in the NMP group for the G2/G2 kidney. Conclusion: Donor kidney pairs with the high-risk APOL1 genotype, especially G2/G2, show increased APOL1 expression and inflammation, particularly under NMP conditions. NMP enables detection of genotype-specific molecular changes in an ischemic reperfusion injury model, supporting its potential to improve donor kidney assessment before transplantation.
Open AccessAPOL1-Risk Genotype Induces Inflammatory and Hypoxic Gene Expression in Donor Kidneys
Background/Objectives: APOL1 renal-risk variants (RRVs) are of increasing relevance to kidney disease and transplant outcomes. It is currently understood that the presence of RRVs in donors negatively impacts kidney allograft survival in an autosomal recessive pattern of inheritance. Less well known is the interplay between ischemia and alternative allograft preservation methods, such as normothermic machine perfusion (NMP), on APOL1 gene expression. To investigate this, we examined the effects of APOL1 RRVs on APOL1 gene expression in ischemic donor kidneys and compared the differences in cytokine and APOL1 expression patterns between the alternative preservation methods, static cold storage (CS) and NMP. Methods: Non-utilized deceased donor kidney pairs from donors of African ancestry were procured from Mid-America Transplant after being deemed unsuitable for kidney transplant. Samples were collected from each donor kidney pair and DNA was extracted for APOL1 genotyping. APOL1 RRVs G1 (rs73885319) (rs60910145) and G2 (rs71785313) were identified by Sanger sequencing. From each pair, one kidney underwent 6 h NMP (n = 3) and the contralateral kidney 6 h of CS (n = 3) following the initial CS. Renal perfusion and biochemical, and histologic parameters were recorded. NMP was directly compared with CS using paired donor kidneys using NMP with allogeneic red blood cells, followed by assessment of perfusion, biochemical, and histologic parameters, in addition to gene expression. Results: Donor genotyping identified kidney pairs as heterozygous for the G1 RRV (G1/G0), homozygous for the G0 allele (G0/G0), and homozygous for the G2 RRV (G2/G2), respectively. All kidneys were successfully reperfused, with mRNA transcript levels of APOL1-related genes subsequently measured. Significant differences in APOL1 gene expression were observed among all three groups of kidneys. In paired kidneys from baseline to hour 6 of NMP, mRNA expression varied significantly between G1/G0 and G2/G2 homozygous pairs (p = 0.002) as well as between the G0/G0 and G2/G2 pairs (p = 0.002). APOL1 expression shifted by a significantly higher-fold change of 2.4 under NMP conditions in the G2/G2 genotype (p < 0.001). The inflammatory cytokine marker IFN-γ was also significantly upregulated in the G2/G2 genotype kidney, in both CS and NMP groups (p = 0.001). Other related genes such as KIM-1 were upregulated by a change of 3.9-fold in the NMP group for the G2/G2 kidney. Conclusion: Donor kidney pairs with the high-risk APOL1 genotype, especially G2/G2, show increased APOL1 expression and inflammation, particularly under NMP conditions. NMP enables detection of genotype-specific molecular changes in an ischemic reperfusion injury model, supporting its potential to improve donor kidney assessment before transplantation.
- Open Access
- 1 July 2025
- Published by Springer Nature in Cureus
- Vol. 17 (7) , e87107
Yttrium-90 Transarterial Radioembolization as a Bridging Therapy to Liver Transplant in a Toddler With Pretreatment Extent (PRETEXT) IV Hepatoblastoma
Hepatoblastoma (HB) is a rare but highly malignant tumor that commonly arises in utero. The mainstay treatment is surgical resection, with adjuvant treatment options including chemotherapy, hepatic artery chemoembolization, and liver transplantation. Yttrium-90 (Y90) transarterial radioembolization (TARE Y90) is a developing treatment option that utilizes radioactive beads delivered specifically to blood vessels supplying the tumor. This treatment method has previously been utilized in the treatment of adult tumors but has rarely been utilized in the pediatric population. In this report, we discuss the case of a toddler with an unresectable HB who underwent TARE Y90 as an adjuvant treatment to chemotherapy, ending in a successful liver transplantation. This patient was a 19-month-old female who presented with an abdominal mass and laboratory findings significant for anemia, thrombocytosis, elevated lactate dehydrogenase (LDH), direct hyperbilirubinemia, and alpha-fetoprotein (AFP) elevation. A computed tomography (CT) scan and magnetic resonance imaging (MRI) displayed a large, multilobular mass involving all lobes of the liver without evidence of metastasis, and biopsy results were consistent with HB. Following four rounds of chemotherapy, an MRI of the abdomen revealed a decrease in tumor size. Due to the continued uptrend of AFP raising concern for lack of control of the tumor, treatment with TARE Y90 microspheres radioembolization as a bridging therapy was initiated. Repeat scans showed an interval increase in the HB size, likely secondary to tumor necrosis with edema and hyperemia. Nine months following the diagnosis, the patient underwent an orthotopic liver transplant and a sixth cycle of chemotherapy. This report illustrates the use of TARE Y90 in a pediatric patient diagnosed with HB, thereby inducing a direct cytotoxic effect on tumor cells. Adjunctive therapy Y90 radioembolization worked by controlling tumor size and AFP levels, facilitating the crucial aspect of liver transplantation with tumor resection with negative margins. The patient did not suffer any of the known side effects of TARE Y90 therapy, which include, but are not limited to, post-embolization syndrome, biliary complications, stricture, cholangitis, pulmonary complications, and gastrointestinal ulcers. This therapy, along with chemotherapy, has the potential to be a novel approach as a bridge to resection or orthotopic liver transplant in HB patients. Further case reports and a manuscript compiling the use of Y90 radioembolization therapy in pediatric HB patients would be useful in evaluating the efficacy of the treatment in pediatric patients.
- 1 July 2025
- Published by Springer Nature in Cureus
- Vol. 17 (7) , e87107
Open AccessYttrium-90 Transarterial Radioembolization as a Bridging Therapy to Liver Transplant in a Toddler With Pretreatment Extent (PRETEXT) IV Hepatoblastoma
Hepatoblastoma (HB) is a rare but highly malignant tumor that commonly arises in utero. The mainstay treatment is surgical resection, with adjuvant treatment options including chemotherapy, hepatic artery chemoembolization, and liver transplantation. Yttrium-90 (Y90) transarterial radioembolization (TARE Y90) is a developing treatment option that utilizes radioactive beads delivered specifically to blood vessels supplying the tumor. This treatment method has previously been utilized in the treatment of adult tumors but has rarely been utilized in the pediatric population. In this report, we discuss the case of a toddler with an unresectable HB who underwent TARE Y90 as an adjuvant treatment to chemotherapy, ending in a successful liver transplantation. This patient was a 19-month-old female who presented with an abdominal mass and laboratory findings significant for anemia, thrombocytosis, elevated lactate dehydrogenase (LDH), direct hyperbilirubinemia, and alpha-fetoprotein (AFP) elevation. A computed tomography (CT) scan and magnetic resonance imaging (MRI) displayed a large, multilobular mass involving all lobes of the liver without evidence of metastasis, and biopsy results were consistent with HB. Following four rounds of chemotherapy, an MRI of the abdomen revealed a decrease in tumor size. Due to the continued uptrend of AFP raising concern for lack of control of the tumor, treatment with TARE Y90 microspheres radioembolization as a bridging therapy was initiated. Repeat scans showed an interval increase in the HB size, likely secondary to tumor necrosis with edema and hyperemia. Nine months following the diagnosis, the patient underwent an orthotopic liver transplant and a sixth cycle of chemotherapy. This report illustrates the use of TARE Y90 in a pediatric patient diagnosed with HB, thereby inducing a direct cytotoxic effect on tumor cells. Adjunctive therapy Y90 radioembolization worked by controlling tumor size and AFP levels, facilitating the crucial aspect of liver transplantation with tumor resection with negative margins. The patient did not suffer any of the known side effects of TARE Y90 therapy, which include, but are not limited to, post-embolization syndrome, biliary complications, stricture, cholangitis, pulmonary complications, and gastrointestinal ulcers. This therapy, along with chemotherapy, has the potential to be a novel approach as a bridge to resection or orthotopic liver transplant in HB patients. Further case reports and a manuscript compiling the use of Y90 radioembolization therapy in pediatric HB patients would be useful in evaluating the efficacy of the treatment in pediatric patients.
- Open Access
- 8 April 2025
- Published by Springer Nature in Cureus
- Vol. 17 (4) , e81915
Association of Low BMI, Elevated Model for End-Stage Liver Disease Score, and Poor Functional Status With Increased 30-Day Readmission After Orthotopic Liver Transplant: A Retrospective Cohort Study
Background Liver transplantation is the ultimate treatment for end-stage liver disease. However, post-transplant management is very complex, with the need for meticulous immunosuppression regimens and multidisciplinary coordinated specialist care. This can be complicated by a higher risk of readmissions after transplant. Readmission rates are now being used as a measure of a facility's efficacy post-transplant. In this study, we investigated recipient characteristics that may place recipients at higher risk for 30-day readmission. Method Chi-square and independent t-test analyses of six variables were performed accordingly on liver transplant recipient data extracted from the Standard Transplant Analysis and Research (STAR) data. The variables were Model for End-Stage Liver Disease (MELD) score, body mass index (BMI), age, diabetes status, hepatitis C status, and functional status. The association between these variables and 30-day readmission rates was investigated. Results We observed six recipient risk factors, including elevated MELD score, positive diabetes mellitus status, positive hepatitis C status, and lower functional status, which increase hospitalization post-transplant. Of the six examined characteristics, lower BMI, elevated MELD score, and lower functional status were significantly associated with 30-day readmission. The t values and P values were as follows: t(38,180) = 4.080, P = 4.514E-05 for BMI; t(38,180) = 4.080, P = 4.514E-05 for MELD score; and t(38,180) = 2.729, P = 6.356E-03 for functional status. Conclusion Our study shows that liver transplant recipients with lower BMI, higher average MELD score, and lower functional status can be identified as high-risk recipients for readmission within 30 days after liver transplant. These findings might help transplant centers anticipate higher complication rates and possibly implement better nutritional optimization prior to transplant and closer follow-up after transplant. Further research could identify specific thresholds for these characteristics that are associated with significantly worse outcomes.
- 8 April 2025
- Published by Springer Nature in Cureus
- Vol. 17 (4) , e81915
Open AccessAssociation of Low BMI, Elevated Model for End-Stage Liver Disease Score, and Poor Functional Status With Increased 30-Day Readmission After Orthotopic Liver Transplant: A Retrospective Cohort Study
Background Liver transplantation is the ultimate treatment for end-stage liver disease. However, post-transplant management is very complex, with the need for meticulous immunosuppression regimens and multidisciplinary coordinated specialist care. This can be complicated by a higher risk of readmissions after transplant. Readmission rates are now being used as a measure of a facility's efficacy post-transplant. In this study, we investigated recipient characteristics that may place recipients at higher risk for 30-day readmission. Method Chi-square and independent t-test analyses of six variables were performed accordingly on liver transplant recipient data extracted from the Standard Transplant Analysis and Research (STAR) data. The variables were Model for End-Stage Liver Disease (MELD) score, body mass index (BMI), age, diabetes status, hepatitis C status, and functional status. The association between these variables and 30-day readmission rates was investigated. Results We observed six recipient risk factors, including elevated MELD score, positive diabetes mellitus status, positive hepatitis C status, and lower functional status, which increase hospitalization post-transplant. Of the six examined characteristics, lower BMI, elevated MELD score, and lower functional status were significantly associated with 30-day readmission. The t values and P values were as follows: t(38,180) = 4.080, P = 4.514E-05 for BMI; t(38,180) = 4.080, P = 4.514E-05 for MELD score; and t(38,180) = 2.729, P = 6.356E-03 for functional status. Conclusion Our study shows that liver transplant recipients with lower BMI, higher average MELD score, and lower functional status can be identified as high-risk recipients for readmission within 30 days after liver transplant. These findings might help transplant centers anticipate higher complication rates and possibly implement better nutritional optimization prior to transplant and closer follow-up after transplant. Further research could identify specific thresholds for these characteristics that are associated with significantly worse outcomes.
- 18 March 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (4) , 569-574
The Use of Intraoperative Transit Time Flow Meter for the Early Detection and Prevention of Vascular Complications Following Adult Deceased Donor Liver Transplantation
- 18 March 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (4) , 569-574
The Use of Intraoperative Transit Time Flow Meter for the Early Detection and Prevention of Vascular Complications Following Adult Deceased Donor Liver Transplantation
- Open Access
- 9 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80313
Surgical Management of a Complex High Hepatic Duct Injury: A Case Report
This is a case of a patient who underwent an elective laparoscopic cholecystectomy after previously presenting with acute cholecystitis. His operation was complicated by a high common hepatic duct (CHD) injury requiring complex surgical repair. This case highlights the importance of the early recognition of this type of injury and the utility of a Kasai portoenterostomy as an operative repair in high CHD injuries in the absence of an extrahepatic duct viable for repair.
- 9 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e80313
Open AccessSurgical Management of a Complex High Hepatic Duct Injury: A Case Report
This is a case of a patient who underwent an elective laparoscopic cholecystectomy after previously presenting with acute cholecystitis. His operation was complicated by a high common hepatic duct (CHD) injury requiring complex surgical repair. This case highlights the importance of the early recognition of this type of injury and the utility of a Kasai portoenterostomy as an operative repair in high CHD injuries in the absence of an extrahepatic duct viable for repair.